These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10607740)

  • 81. Smoking intensity and bladder cancer aggressiveness at diagnosis.
    Barbosa ALA; Vermeulen SHHM; Aben KK; Grotenhuis AJ; Vrieling A; Kiemeney LA
    PLoS One; 2018; 13(3):e0194039. PubMed ID: 29570711
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4
    Hammam O; Magdy M; Badawy M; Osili KA; Kholy AE; LeitHy TE
    Open Access Maced J Med Sci; 2017 Aug; 5(5):578-586. PubMed ID: 28932295
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Does quantification of smoking history correlate with initial bladder tumor grade and stage?
    Pietzak EJ; Malkowicz SB
    Curr Urol Rep; 2014 Jul; 15(7):416. PubMed ID: 24832198
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic instability persists in non-neoplastic urothelial cells from patients with a history of urothelial cell carcinoma.
    de Castro Marcondes JP; de Oliveira ML; Gontijo AM; de Camargo JL; Salvadori DM
    PLoS One; 2014; 9(1):e86162. PubMed ID: 24465937
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Intervention of nicotine on MNU-induced bladder cancer in rats.
    Liu D; Pan F; Li B; Han X; Li W; Shi Y; Pang Z; Zhang Q
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):103-106. PubMed ID: 21336733
    [TBL] [Abstract][Full Text] [Related]  

  • 86. P53 mutations in urinary bladder cancer patients from Central Poland.
    Borkowska E; Binka-Kowalska A; Constantinou M; Nawrocka A; Matych J; Kałuzewski B
    J Appl Genet; 2007; 48(2):177-83. PubMed ID: 17495352
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
    Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
    Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
    Lianes P; Orlow I; Zhang ZF; Oliva MR; Sarkis AS; Reuter VE; Cordon-Cardo C
    J Natl Cancer Inst; 1994 Sep; 86(17):1325-30. PubMed ID: 8064890
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 91. P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.
    LaRue H; Allard P; Simoneau M; Normand C; Pfister C; Moore L; Meyer F; Têtu B; Fradet Y
    Carcinogenesis; 2000 Jan; 21(1):101-6. PubMed ID: 10607740
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.